TCL Archive Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer February 25, 2011
TCL Archive DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards November 5, 1982